Lucy Scientific Discovery downsizes IPO again to $7.5M

Large yellow signboard on metal frame with the word IPO


  • Psychotropic drug contract manufacturer Lucy Scientific Discovery (LSDI) on Wednesday downsized its proposed IPO again to ~$7.5M from $8M earlier.
  • The firm priced its IPO of ~1.88M shares at $4 apiece.
  • Underwriters have been granted a 45 day over-allotment option to buy an additional 15% or ~281.3K shares.
  • The shares are expected to begin trading on Nasdaq Capital Market on February 9 under the ticker 'LSDI'.
  • The IPO is expected to close on February 13.
  • Late last year, Lucy Scientific (LSDI) had downsized its proposed IPO to $8M.

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.